NIH-funded research R01 grant

Understanding how genetic changes in blood cells relate to heart disease in people with HIV

Official title: Evaluation of Novel Clonal Hematopoiesis Of InDEterminate Potential, Mosaic Chromosomal Alterations and CardioVascular Disease in HIV Infection (ENCODE CVD in HIV)

Funded at University of California Los Angeles · NIH-11642564 · Data updated 2026-11-12

A study will look at how age-related blood cell mutations and large chromosomal changes might contribute to heart disease risk in people living with HIV.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California Los Angeles
NIH-funded
Lab location1 site (Los Angeles, United States)
Project startJuly 5, 2023
Project endJune 30, 2027
Funding year2026
Award (this year)$175,455
NIH project number3R01HL170600-04S1
Project IDNIH-11642564 on NIH RePORTER

Who could benefit from this research

Could help

People with HIV who are aging and at risk for cardiovascular disease.

Less likely to help

Individuals without HIV or without cardiovascular risk factors may see limited direct benefit.

What this research studies

This project will enroll people living with HIV as they age to examine whether specific blood cell mutations and chromosomal changes are linked to higher rates of cardiovascular disease. Researchers will analyze blood samples to identify clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs), and relate these findings to cardiovascular outcomes. By investigating immune pathways such as NLRP3/IL-1β/IL-6, the study aims to uncover biological connections between HIV, aging, and heart health. The results could point to new biomarkers or pathways for preventing heart disease in PLWH.

Why it matters

Potential benefit: If successful, the study could identify novel biomarkers and pathways that help predict and prevent heart disease in people living with HIV.

How similar studies have gone: Previous work shows CHIP and mCAs are linked to cardiovascular risk in the general population, but their role in HIV is not well understood and this study extends that knowledge.

Where this research is happening

  • University of California Los Angeles
    Los Angeles, United States
    Active

Researchers

  • Principal investigator: Hsue, Priscilla Y. — University of California Los Angeles
  • Study coordinator: Hsue, Priscilla Y.

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.